Skip to main content
. Author manuscript; available in PMC: 2014 Jan 1.
Published in final edited form as: Stat Biopharm Res. 2013 Sep 11;5(3):10.1080/19466315.2013.795910. doi: 10.1080/19466315.2013.795910

Figure 5.

Figure 5

Curves showing the relationship between the number of events in historical trial(s) and analytical estimates of across-trial rejection probabilities when β̂PS,H = ln(1.58) = 0.46, β̂ES = ln(1.1) = 0.095, and v̂ar(β̂ES) = 4/400 = 0.01. If βPS= (1 − 0.58)E[β̂PS,H] , then βES = 0.5βPS, and under the preservation of effect hypothesis with p = 0.5 , we wish to control the non-inferiority test rejection probability below 0.025. Synthesis(λ, p) and Bias-adjusted(λ, p) were evaluated for a range of λ and a fixed p = 0.5.